Mitochondrial DNA sequencing in samples of Huntington’s disease patients

Mitochondrial dysfunction is found in the brain and peripheral tissues of Huntington’s disease (HD) patients, which connects many pathological features of HD. In this project, we conducted a large-scale study of mtDNA variations with a sensitive mtDNA-targeted sequencing method called STAMP, at a median coverage of 4000-fold, in lymphoblast and blood samples of HD patients. mtDNA sequence variations and copy numbers were compared between samples from HD patients and healthy control individuals, and were assessed in relation to HD stages, and changes of HD phenotypes in longitudinal samples.

Type: Other
Archiver: European Genome-Phenome Archive (EGA)

1 Dataset 2 Publications

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID	Description	Technology	Samples
EGAD00001005723	This dataset contains sequencing data from a large-scale study of mtDNA variations measured, using a sensitive mtDNA-targeted sequencing method called STAMP, in lymphoblast and blood samples of Huntington’s Disease patients.	Illumina HiSeq 2500	2602

Publications	Citations
STAMP: a multiplex sequencing method for simultaneous evaluation of mitochondrial DNA heteroplasmies and content. Guo X, Wang Y, Zhang R, Gu Z. NAR Genom Bioinform 2: 2020 lqaa065	6
Accelerated expansion of pathogenic mitochondrial DNA heteroplasmies in Huntington's disease. Wang Y, Guo X, Ye K, Orth M, Gu Z. Proc Natl Acad Sci U S A 118: 2021 e2014610118	17